Recommended Dose for Lurasidone
For bipolar depression in adults, start lurasidone at 20 mg once daily with food (at least 350 calories), with an effective dose range of 20-120 mg/day and a maximum dose of 120 mg/day. 1
Standard Dosing by Indication
Bipolar Depression (FDA-Approved)
Adults:
- Starting dose: 20 mg once daily 1
- Effective range: 20-120 mg/day 1
- Maximum dose: 120 mg/day 1
- No initial titration required 1
- Clinical trials showed the higher dose range (80-120 mg/day) did not provide additional efficacy compared to lower doses (20-60 mg/day) 1
Pediatric patients (10-17 years):
- Starting dose: 20 mg once daily 1
- Effective range: 20-80 mg/day 1
- Maximum dose: 80 mg/day 1
- May increase after one week based on clinical response 1
- Most patients (67%) in clinical trials received 20-40 mg/day 1
Schizophrenia (Referenced in Research)
- Starting dose: 40 mg/day 2, 3, 4
- Recommended range: 40-80 mg/day 2, 3
- Extended range: Up to 160 mg/day has been studied 5, 2
- Doses above 80 mg/day may not confer additional benefit and can increase adverse effects like somnolence and akathisia 2, 3
Critical Administration Requirements
Must be taken with food containing at least 350 calories 1
- Administration with food increases AUC approximately 2-fold and Cmax approximately 3-fold 1
- This is not optional—absorption is substantially reduced without food 1
Dose Modifications for Special Populations
Renal Impairment
- Moderate impairment (CrCl 30-50 mL/min): Start at 20 mg/day, maximum 80 mg/day 1
- Severe impairment (CrCl <30 mL/min): Start at 20 mg/day, maximum 80 mg/day 1
Hepatic Impairment
- Moderate impairment (Child-Pugh 7-9): Start at 20 mg/day, maximum 80 mg/day 1
- Severe impairment (Child-Pugh 10-15): Start at 20 mg/day, maximum 40 mg/day 1
Drug Interactions
With moderate CYP3A4 inhibitors (diltiazem, erythromycin, fluconazole, verapamil):
- If adding inhibitor to existing lurasidone: Reduce lurasidone dose to half 1
- If adding lurasidone to existing inhibitor: Start at 20 mg/day, maximum 80 mg/day 1
Strong CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir) are contraindicated 1
Strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St. John's wort) are contraindicated 1
Grapefruit and grapefruit juice must be avoided as they inhibit CYP3A4 1
Key Safety Considerations
- Metabolic profile: Lurasidone is associated with minimal weight gain and no clinically meaningful alterations in glucose, lipids, or QTc interval 5, 2, 3, 4
- Common adverse effects: Somnolence, akathisia, nausea, and parkinsonism, particularly early in treatment 5, 4
- Long-term use: Effectiveness beyond 6 weeks has not been established in controlled studies; periodically re-evaluate continued use 1
Clinical Decision Algorithm
- Confirm indication: Bipolar depression (approved) vs. schizophrenia (different dosing) 1
- Assess organ function: Check renal and hepatic function to determine if dose adjustment needed 1
- Review medications: Screen for CYP3A4 inhibitors/inducers and adjust accordingly 1
- Start at 20 mg once daily with food (≥350 calories) for bipolar depression 1
- Titrate based on response: Can increase dose, but recognize that higher doses may not provide additional benefit in bipolar depression 1
- Monitor for akathisia and somnolence, especially in first few weeks 5, 4